Watchlist: Technical Breakout from Gilead Sciences Inc (GILD)

Technical Breakout from Gilead Sciences Inc (GILD)

Biotech Gilead Sciences Inc (GILD) is breaking out technically which made a six-month high today with a +5% gap-up. 

The press release of Gilead to Acquire Remaining Worldwide Rights of Trodelvy could be a triggering event. The breast cancer drug from Trodelvy is already in the process of FDA approval for overall survival (OS) in the Phase 3 TROPiCS-02 study evaluating Trodelvy. 

Its technical breakout pattern offers an ideal entry point and sell-stop as shown.

Share This Post
Have your say!
00

Leave a Reply